ID   PA2GA_RAT               Reviewed;         146 AA.
AC   P14423;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 2.
DT   29-MAY-2024, entry version 188.
DE   RecName: Full=Phospholipase A2, membrane associated;
DE            EC=3.1.1.4 {ECO:0000269|PubMed:3356705};
DE   AltName: Full=GIIC sPLA2;
DE   AltName: Full=Group IIA phospholipase A2;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 2A;
DE   Flags: Precursor;
GN   Name=Pla2g2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Platelet;
RX   PubMed=2606907; DOI=10.1093/oxfordjournals.jbchem.a122890;
RA   Komada M., Kudo I., Mizushima H., Kitamura N., Inoue K.;
RT   "Structure of cDNA coding for rat platelet phospholipase A2.";
RL   J. Biochem. 106:545-547(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Spleen;
RX   PubMed=2346480; DOI=10.1016/0006-291x(90)91137-h;
RA   Komada M., Kudo I., Inoue K.;
RT   "Structure of gene coding for rat group II phospholipase A2.";
RL   Biochem. Biophys. Res. Commun. 168:1059-1065(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2764915; DOI=10.1016/0006-291x(89)90777-8;
RA   Ishizaki J., Ohara O., Nakamura E., Tamaki M., Ono T., Kanda A.,
RA   Yoshida N., Teraoka H., Tojo H., Okamoto M.;
RT   "cDNA cloning and sequence determination of rat membrane-associated
RT   phospholipase A2.";
RL   Biochem. Biophys. Res. Commun. 162:1030-1036(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2400792; DOI=10.1016/0167-4781(90)90127-n;
RA   Kusunoki C., Satoh S., Kobayashi M., Niwa M.;
RT   "Structure of genomic DNA for rat platelet phospholipase A2.";
RL   Biochim. Biophys. Acta 1087:95-97(1990).
RN   [5]
RP   PROTEIN SEQUENCE OF 22-146.
RC   STRAIN=Wistar; TISSUE=Platelet;
RX   PubMed=3235451; DOI=10.1093/oxfordjournals.jbchem.a122547;
RA   Hayakawa M., Kudo I., Tomita M., Nojima S., Inoue K.;
RT   "The primary structure of rat platelet phospholipase A2.";
RL   J. Biochem. 104:767-772(1988).
RN   [6]
RP   PROTEIN SEQUENCE OF 22-57, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Spleen;
RX   PubMed=3356705; DOI=10.1016/s0021-9258(18)60626-x;
RA   Ono T., Tojo H., Kuramitsu S., Kagamiyama H., Okamoto M.;
RT   "Purification and characterization of a membrane-associated phospholipase
RT   A2 from rat spleen. Its comparison with a cytosolic phospholipase A2 S-1.";
RL   J. Biol. Chem. 263:5732-5738(1988).
RN   [7]
RP   PROTEIN SEQUENCE OF 22-46.
RC   TISSUE=Platelet;
RX   PubMed=3654593; DOI=10.1093/oxfordjournals.jbchem.a121996;
RA   Hayakawa M., Horigome K., Kudo I., Tomita M., Nojima S., Inoue K.;
RT   "Amino acid composition and NH2-terminal amino acid sequence of rat
RT   platelet secretory phospholipase A2.";
RL   J. Biochem. 101:1311-1314(1987).
RN   [8]
RP   PROTEIN SEQUENCE OF 22-45, AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=2722857; DOI=10.1016/s0021-9258(18)81760-4;
RA   Aarsman A.J., de Jong J.G.N., Arnoldussen E., Neys F.W.,
RA   van Wassenaar P.D., van den Bosch H.;
RT   "Immunoaffinity purification, partial sequence, and subcellular
RT   localization of rat liver phospholipase A2.";
RL   J. Biol. Chem. 264:10008-10014(1989).
CC   -!- FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily
CC       targets extracellular phospholipids with implications in host
CC       antimicrobial defense, inflammatory response and tissue regeneration
CC       (By similarity). Hydrolyzes the ester bond of the fatty acyl group
CC       attached at sn-2 position of phospholipids (phospholipase A2 activity)
CC       with preference for phosphatidylethanolamines and phosphatidylglycerols
CC       over phosphatidylcholines (PubMed:3356705). Contributes to lipid
CC       remodeling of cellular membranes and generation of lipid mediators
CC       involved in pathogen clearance. Displays bactericidal activity against
CC       Gram-positive bacteria by directly hydrolyzing phospholipids of the
CC       bacterial membrane. Upon sterile inflammation, targets membrane
CC       phospholipids of extracellular mitochondria released from activated
CC       platelets, generating free unsaturated fatty acids such as arachidonate
CC       that is used by neighboring leukocytes to synthesize inflammatory
CC       eicosanoids such as leukotrienes. Simultaneously, by compromising
CC       mitochondrial membrane integrity, promotes the release in circulation
CC       of potent damage-associated molecular pattern molecules that activate
CC       the innate immune response (By similarity). Plays a stem cell regulator
CC       role in the intestinal crypt. Within intracellular compartment mediates
CC       Paneth cell differentiation and its stem cell supporting functions by
CC       inhibiting Wnt signaling pathway in intestinal stem cell (ICS).
CC       Secreted in the intestinal lumen upon inflammation, acts in an
CC       autocrine way and promotes prostaglandin E2 synthesis that stimulates
CC       Wnt signaling pathway in ICS cells and tissue regeneration (By
CC       similarity). May play a role in the biosynthesis of N-acyl
CC       ethanolamines that regulate energy metabolism and inflammation.
CC       Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl
CC       lysophosphatidylethanolamines, which are further cleaved by a
CC       lysophospholipase D to release N-acyl ethanolamines. Independent of its
CC       catalytic activity, acts as a ligand for integrins. Binds to and
CC       activates integrins ITGAV:ITGB3, ITGA4:ITGB1 and ITGA5:ITGB1. Binds to
CC       a site (site 2) which is distinct from the classical ligand-binding
CC       site (site 1) and induces integrin conformational changes and enhanced
CC       ligand binding to site 1. Induces cell proliferation in an integrin-
CC       dependent manner (By similarity). {ECO:0000250|UniProtKB:P14555,
CC       ECO:0000250|UniProtKB:P31482, ECO:0000269|PubMed:3356705}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + H2O = a 1-
CC         acyl-sn-glycero-3-phosphoethanolamine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:44604, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:64381, ChEBI:CHEBI:64612;
CC         Evidence={ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44605;
CC         Evidence={ECO:0000305|PubMed:3356705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphoethanolamine + H(+); Xref=Rhea:RHEA:40911,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:73004, ChEBI:CHEBI:73007;
CC         Evidence={ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40912;
CC         Evidence={ECO:0000305|PubMed:3356705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40815, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:73004, ChEBI:CHEBI:73008;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40816;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40432;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-hexadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = (9Z)-octadecenoate + H(+) + N-hexadecanoyl-1-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:45424, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:78097, ChEBI:CHEBI:85217;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45425;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) + H2O
CC         = 1-hexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:45472, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:72829,
CC         ChEBI:CHEBI:75158; Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45473;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoglycerol + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphoglycerol + H(+); Xref=Rhea:RHEA:44524,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:84472, ChEBI:CHEBI:84475;
CC         Evidence={ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44525;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-
CC         sn-glycerol) + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-
CC         3-phospho-(1'-sn-glycerol) + H(+); Xref=Rhea:RHEA:40919,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:72841, ChEBI:CHEBI:75158;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40920;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10035, ECO:0000255|PROSITE-
CC         ProRule:PRU10036, ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000305|PubMed:3356705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000305|PubMed:3356705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (9Z,12Z)-octadecadienoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40811,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:73002;
CC         Evidence={ECO:0000269|PubMed:3356705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40812;
CC         Evidence={ECO:0000305|PubMed:3356705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycero-3-phosphocholine + H2O = (4Z,7Z,10Z,13Z,16Z,19Z)-
CC         docosahexaenoate + 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:41231, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:74963, ChEBI:CHEBI:77016;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41232;
CC         Evidence={ECO:0000250|UniProtKB:P14555};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:3356705};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250|UniProtKB:P14555};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8-9.5. {ECO:0000269|PubMed:3356705};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2722857}. Cell
CC       membrane {ECO:0000269|PubMed:2722857}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P14555}. Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:P14555}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P14555}.
CC   -!- MISCELLANEOUS: Group II phospholipase A2 is found in many cells and
CC       also extracellularly. The membrane-bound and secreted forms are
CC       identical and are encoded by a single gene.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D00523; BAA00410.1; -; mRNA.
DR   EMBL; M37127; AAA41223.1; -; Genomic_DNA.
DR   EMBL; M25148; AAA41920.1; -; mRNA.
DR   EMBL; X51529; CAA35909.1; -; Genomic_DNA.
DR   PIR; A33394; A33394.
DR   PIR; A35493; A35493.
DR   PIR; JU0283; JU0283.
DR   PIR; JX0052; JX0052.
DR   RefSeq; NP_113786.3; NM_031598.3.
DR   RefSeq; XP_006239208.1; XM_006239146.2.
DR   AlphaFoldDB; P14423; -.
DR   SMR; P14423; -.
DR   CORUM; P14423; -.
DR   STRING; 10116.ENSRNOP00000022827; -.
DR   BindingDB; P14423; -.
DR   ChEMBL; CHEMBL3686; -.
DR   PhosphoSitePlus; P14423; -.
DR   PaxDb; 10116-ENSRNOP00000022827; -.
DR   Ensembl; ENSRNOT00000022827.5; ENSRNOP00000022827.3; ENSRNOG00000016945.6.
DR   Ensembl; ENSRNOT00055039261; ENSRNOP00055031846; ENSRNOG00055022870.
DR   Ensembl; ENSRNOT00060055340; ENSRNOP00060045784; ENSRNOG00060031914.
DR   GeneID; 29692; -.
DR   KEGG; rno:29692; -.
DR   UCSC; RGD:620857; rat.
DR   AGR; RGD:620857; -.
DR   CTD; 5320; -.
DR   RGD; 620857; Pla2g2a.
DR   eggNOG; KOG4087; Eukaryota.
DR   GeneTree; ENSGT00940000155096; -.
DR   HOGENOM; CLU_090683_3_0_1; -.
DR   InParanoid; P14423; -.
DR   OMA; GDQDYCK; -.
DR   OrthoDB; 638584at2759; -.
DR   PhylomeDB; P14423; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-RNO-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-RNO-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-RNO-1483166; Synthesis of PA.
DR   Reactome; R-RNO-6803157; Antimicrobial peptides.
DR   PRO; PR:P14423; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016945; Expressed in jejunum and 18 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:RGD.
DR   GO; GO:0004623; F:phospholipase A2 activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0036335; P:intestinal stem cell homeostasis; ISS:UniProtKB.
DR   GO; GO:0031640; P:killing of cells of another organism; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; TAS:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IBA:GO_Central.
DR   GO; GO:0046473; P:phosphatidic acid metabolic process; ISO:RGD.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; ISS:UniProtKB.
DR   GO; GO:0046337; P:phosphatidylethanolamine metabolic process; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0001936; P:regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:1902563; P:regulation of neutrophil activation; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:RGD.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; Phospholipase A2 domain; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PHOSPHOLIPASE A2 FAMILY MEMBER; 1.
DR   PANTHER; PTHR11716:SF9; PHOSPHOLIPASE A2, MEMBRANE ASSOCIATED; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; Phospholipase A2, PLA2; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Antimicrobial; Bacteriolytic enzyme; Calcium; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Inflammatory response; Lipid degradation; Lipid metabolism; Membrane;
KW   Metal-binding; Mitochondrion; Mitochondrion outer membrane;
KW   Phospholipid metabolism; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:2722857,
FT                   ECO:0000269|PubMed:3235451, ECO:0000269|PubMed:3356705,
FT                   ECO:0000269|PubMed:3654593"
FT   CHAIN           22..146
FT                   /note="Phospholipase A2, membrane associated"
FT                   /id="PRO_0000022752"
FT   ACT_SITE        68
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        113
FT                   /evidence="ECO:0000250"
FT   BINDING         48
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   BINDING         50
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   BINDING         52
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   BINDING         69
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   SITE            122
FT                   /note="Important for integrin binding"
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        47..139
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        49..65
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        64..119
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        70..146
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        71..112
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        80..105
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   DISULFID        98..110
FT                   /evidence="ECO:0000250|UniProtKB:P14555"
FT   VARIANT         135
FT                   /note="P -> L"
FT   CONFLICT        22
FT                   /note="S -> D (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        63
FT                   /note="W -> E (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="D -> E (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="R -> S (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        85
FT                   /note="L -> V (in Ref. 3; AAA41920)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="A -> S (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   146 AA;  16294 MW;  60DDC9E79BF109F7 CRC64;
     MKVLLLLAVV IMAFGSIQVQ GSLLEFGQMI LFKTGKRADV SYGFYGCHCG VGGRGSPKDA
     TDWCCVTHDC CYNRLEKRGC GTKFLTYKFS YRGGQISCST NQDSCRKQLC QCDKAAAECF
     ARNKKSYSLK YQFYPNKFCK GKTPSC
//
